Professor Leah Cowan is the Canada Research Chair in Microbial Genomics & Infectious Disease, co-Director of the CIFAR Fungal Kingdom: Threats & Opportunities program, and former Chair of the Department of Molecular Genetics at the University of Toronto. Until December 2021 she served as the University of Toronto’s first Associate Vice-President, Research. She received her undergraduate degree from the University of British Columbia, a PhD from the University of Toronto, and pursued postdoctoral studies at the Whitehead Institute. Her laboratory takes an interdisciplinary approach to understand what allows some microbes to exploit the host and cause disease, and to develop new strategies to treat life-threatening infectious disease.
Professor Cowen has an outstanding track record of excellence in research, scholarship, and education. She has been recognized with a myriad of awards, including a Burroughs Wellcome Fund Career Award, Grand Challenges Canada Star in Global Health Award, Merck Irving S. Sigal Memorial Award, E.W.R. Steacie Award, and Canada Research Chair in Microbial Genomics & Infectious Disease (Tier I and Tier II). She has been elected as Fellow of the American Academy of Microbiology and Fellow of the American Association for the Advancement of Science. She is advancing knowledge translation as co-Founder and Chief Scientific Officer of Bright Angel Therapeutics, a company that leverages state-of-the-art technologies for development of novel antifungal therapeutics.